Opko Health logo

Opko Health (OPK) Q3 2024 Earnings

OPK·Reported November 7, 2024·After market close

Opko Health reported Q3 2024 revenue of $173.6M, beat analyst consensus of $155.4M by $18.2M. Diluted EPS came in at $0.03, beat the $-0.10 consensus by $0.13.

Revenue
$173.6Mbeat by $18.2M
Consensus: $155.4M
Diluted EPS
$0.03beat by $0.13
Consensus: $-0.10
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q3 2024

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric

Q3 2024 Earnings FAQ

Common questions about Opko Health's Q3 2024 earnings report.

Opko Health (OPK) reported Q3 2024 earnings on November 7, 2024 after market close.

Opko Health reported revenue of $173.6M and diluted EPS of $0.03 for Q3 2024.

Revenue beat the consensus estimate of $155.4M by $18.2M. EPS beat the consensus estimate of $-0.10 by $0.13.

You can read the 10-Q periodic report (0001437749-24-033931) directly on SEC EDGAR. The filing index links above go to sec.gov.